中国SXT制药将合并1比150

2026-01-30 22:36

China SXT Pharmaceutics (Nasdaq: SXTC) Friday said that it will implement a 1-for-150 share consolidation effective February 3, 2026.
The company’s Class A ordinary shares are expected to begin trading on a post-consolidation basis on Nasdaq on that date under the symbol “SXTC,” with a new CUSIP number.
Fractional shares will be rounded up to the next whole share.
China SXT said it had about 143.7 million Class A shares outstanding before the consolidation, which will be reduced to roughly 957,960 shares after the consolidation.
All outstanding options, warrants, and other rights to purchase Class A shares will be adjusted proportionately.

More on China SXT Pharmaceuticals